http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#Head http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#assertion http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#provenance http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#pubinfo http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#assertion http://purl.obolibrary.org/obo/DOID_13884 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_13884 http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00489 http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#association http://www.w3.org/2000/01/rdf-schema#label "SORINE (sotalol hydrochloride) tablets are contraindicated in patients with: Sinus bradycardia, sick sinus syndrome, second and third degree AV block, unless a functioning pacemaker is present Congenital or acquired long QT syndromes Cardiogenic shock or decompensated heart failure Serum potassium <4 mEq/L Bronchial asthma or related bronchospastic conditions Hypersensitivity to sotalol For the treatment of AFIB/AFL, SORINE (sotalol hydrochloride) tablets are also contraindicated in patients with: Baseline QT interval >450 ms Creatinine clearance <40 mL/min For the treatment of AFIB/AFL or ventricular arrhythmias Sinus bradycardia, 2 nd rd 4 Congenital or acquired long QT syndrome ( 4 Serum potassium <4 mEq/L( 4 Cardiogenic shock, decompensated heart failure ( 4 Bronchial asthma or related bronchospastic conditions ( 4 Hypersensitivity to sotalol ( 4 For the treatment of AFIB/AFL also contraindicated for: QT interval >450 ms ( 4 Creatinine clearance <40 mL/min ( 4" http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#association https://w3id.org/biolink/vocab/relation https://schema.org/MedicalContraindication https://identifiers.org/drugbank:DB00489 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#provenance http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#pubinfo http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#sig http://purl.org/nanopub/x/hasSignature VSHPKdmtZp4YPGIzA5Vilm3iE46WumMcSAEqbDV9Pen8Q7CHQDPZLPhwuP3jRFizxYx+WOnLVaF/kPls8usdKif2zqEh6YYcJFmdBfFOtvQ4UQyqqKOkWw9Xjvk1HbrrIUSJqNb0AeZcZnut2WEbxXTDYdFSFwbgR6sC4CNcCMA= http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs http://purl.org/dc/terms/created 2021-08-23T12:23:16.631+02:00 http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY